Search results for

Welcome to the eighth edition of Managing IP's India Focus. We have a diverse selection of articles this year that shows the wide range of issues facing India's IP system. These vary from questions over software patents and the patentability of pharmaceutical products to missing files at the trade mark office and accession to the Madrid Protocol. As this supplement goes to press, a key case dealing with the patentability of Novartis's anti-cancer drug Glivec is being argued at the Supreme Court. Patent practitioners are hoping the judgment may finally shed some light on the notorious Section 3(d) of the country's Patent Act. And in the Monsoon session of Parliament India's politicians may pass far-reaching amendments to the country's Copyright Act.

Prietika Siingh and Dheeraj Seth of Inttl Advocare present an overview of the progress that has been made in protecting traditional knowledge and geographical indications in India

Allen F Tao of Liu, Shen & Associates describes the most significant recent patent cases, and finds that time is always of the essence

Nabila Ambadar of Am Badar & Partners explains the value of negotiating and recording a trade mark licence agreement. Even if you can’t make it official

Anuradha Salhotra and Sai Priya Chatterjee of Lall Lahiri & Salhotra explain how far back all aspects of Indian IP law go, and how they have influenced current legislation

Proposed amendments to India’s Copyright Act have proven controversial. In a roundtable held in Delhi in July, Peter Ollier asked specialists about the reforms to the rights of authors, lyricists and composers and to the law on parallel imports

Jakkrit Kuanpoth of Tilleke & Gibbins looks at the ins and outs of the Free Trade Agreement that will bring Australia and New Zealand closer to their developing neighbours

The US Federal Circuit has weighed in on yet another patent eligibility case following the Supreme Court’s In re Bilski ruling, finding two of the three claims in Classen v Biogen to be patentable subject matter

The USPTO is prepared to begin implementing patent reform as soon as the America Invents Act clears Congress and is signed into law, a top official said yesterday

With a top official of the USPTO saying the agency is prepared to begin enacting patent reform legislation as soon as mid-September, representatives of small business interests yesterday warned the America Invents Act could harm innovation